What's breaking now, across thousands of outlets.
Plus news about ADC Therapeutics, Atrium Therapeutics, Bristol Myers, Novartis and Pfizer. Biohaven partners with Ono: Tokyo-based Ono Pharmaceutical has agreed to pay Biohaven $80 million upfront to license its pan-IgG ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Endeavor BioMedicines said its treatment for a chronic lung disease succeeded in a mid-stage test, claiming the drug had the potential to reverse the course of idiopathic pulmonary fibrosis in a ...
The season usually starts in October or November. But some western states, including California, Washington, Alaska and Hawaii, began seeing a rise in flu cases as early as August
The struggling cell therapy developer is exploring strategic alternatives, which, among other characteristics, make it a likely candidate to receive reverse merger interest.
[Capital FM] Nairobi -- East Africa has four years to deliver on its 2030 malaria elimination ambition, but lessons from China's seven-decade journey suggest the region must move faster from broad…
[Capital FM] Nairobi -- East Africa has four years to deliver on its 2030 malaria elimination ambition, but lessons from China's seven-decade journey suggest the region must move faster from broad…
The Nursing and Midwifery Council of Nigeria has urged 78 newly inducted nurses from Elizade University to uphold ethics and prioritise patients in their p Read More…
